NCT01480843

Simplified Insulin Protocol Using Lantus in Elderly

Simplification of Diabetes Regimen in Elderly Patients Using Glargine

• Status: Completed
• Phase: Phase 4
• Study type: Interventional
• Enrollment: 65 (actual)
• Sponsor: Joslin Diabetes Center · Academic / Other
• Sex: All
• Age: 70 Years
• Healthy volunteers: Not accepted

Summary

The purpose of this study is to find out if simplifying your diabetes treatment by decreasing number of insulin injections, with the help of a long acting insulin called glargine, can decrease the episodes of low blood glucose.

Detailed description

As patients with diabetes age, adverse social and medical problems may arise. Because of these problems patients, even those managing their diabetes for many years, find it difficult to continue with complicated insulin schedules. This may lead to errors in treatment and poor glucose control. Simplification of treatment has been found to the decrease risk of low blood glucose, a very dangerous condition at this age. In a previous study, the investigators found that simplifying treatment did not cause the blood sugars to rise out of control. In this study, the investigators plan to simplify insulin treatment and monitor for low glucose episodes with help of a continuous glucose monitor and A1C (measure of average glucose control over 3 months). The investigators will simplify the treatment by adding glucose lowering medications that you can take by mouth, in addition to the injection of long acting insulin called glargine.

Conditions

• Diabetes

Interventions

Type	Name	Description
DRUG	Glargine	Use of glargine with/without other glucose lowering agent to simplify insulin regimen in older adults

Timeline

• Start date: 2011-06-01
• Primary completion: 2015-09-01
• Completion: 2015-09-01
• First posted: 2011-11-29
• Last updated: 2017-11-08
• Results posted: 2017-11-08

Locations

1 site across 1 country: United States